One Drop received $6.1 million from the investors in an equity round according to the SEC file registered.
The raise comes just over a year after the Germantown-based company raised $45 million in an initial public offering.
Building on the largest enrollment quarter in the company’s history, Omada Health today announced a $50 million fundraising round led by global health services leader Cigna (NYSE: CI). In addition to leading the fundraising round, Cigna will also grow its non-exclusive commercial partnership with Omada, adding the recognized Omada Program to Cigna’s suite of health improvement services. Joining the Cigna-led fundraising round were new investors Civilization Ventures and Sanofi Genzyme BioVentures.
Amalgam Rx received $1.2 million in an equity round from the investors according to the SEC file registered.
The £500,000 investment comes from a number of backers, including 500 Startups — an American venture capital firm, Bethnal Green Ventures — an accelerator for start-ups with a social purpose, and private angels.
EIT Health Spain holds its II Annual Conference EIT Health Spain grants 50,000€ of funding to 5 Spanish start-ups selected in the Headstart 2017 call. Among these five companies is ONALABS Inno-Hub S.L. with its digital wearable project with embedded microsensors for continuous monitoring of chronic patients with cardiac and pneumological pathologies.
DayTwo, a leader in microbiome-health management, announced today it has completed a $12.0 million Series A round of financing through Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Seventure Partners' Health for Life Capital fund, Mayo Clinic, co-founder Marius Nacht, and other private investors.
Nutrition focused telehealth startup Fruit Street Health had raised $3 million from physician investors in a fresh round of funding this week. The New York company integrates telemedicine, activity trackers, and medical devices into a program to help physicians and dieticians monitor and check in with patients as part of a diabetes prevention program. DPP is a structured intervention program designed to halt people deemed at risk.
The French startup, which has just raised 13.5 million euros, plans to launch its connected insulin pump for type 1 diabetics on the European and American markets in 2018 and 2019. If its device is not fully automated , Diabeloop believes it has the most efficient system in the world.
Digital health start-up Gendius has completed a series A undisclosed funding round to launch an app-based platform to help people living with diabetes better manage their condition. The Cheshire-based company secured the undisclosed investment from the GM&C Life Sciences Fund, which is managed by Catapult Ventures.